SCHEMBL25848191

SCHEMBL25848191

C=C(C)C(=O)OCC(C)(C)COc1ccc2cc(-c3ccc(CCCCC)cc3OC)c(=O)oc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
GAA P10253 4/20 0.41
GLA P06280 3/20 0.41
LMNA P02545 2/20 0.41
NOD2 Q9HC29 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAOB P27338 4/20 0.40
MAOA P21397 1/20 0.40
S1PR1 P21453 1/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ATM Q13315 2/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848187 0.92 MAOB (0.37) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL22624963 0.91 NPC1 (0.40) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL25848182 0.91 MAOB (0.40) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL25848183 0.91 MAOB (0.40) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL22624962 0.90 NPC1 (0.41) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL22625396 0.90 NPC1 (0.39) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL25848189 0.89 THRB (0.41) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL22625002 0.89 NPC1 (0.40) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL25848161 0.86 NPC1 (0.42) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL22625415 0.86 MAOB (0.42) NPC1RAB9AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 NPC1 1051/4885RAB9A 1916/4885KDM4E 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.